RE:Like I said, management needs to follow up on statements ...Thanks for the excerpt.
Please read:
BVT is working with regulatory consultants in Europe to develop the best strategy to pursue submission for the EU regulatory approval process of its proprietary biological plant protection product CR-7 (Clonostachys rosea strain CR-7). The Company could kick start EU submission later in 2021 depending on the outcome of the current exploratory phase.
Approvals take time. They have entire organizations dedicated to validating every submission.
Management has been executing according to plan.